RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Punch cancer trial: radiation and immune drugs team up
Disease control CompletedThis study tested whether combining a short, intense course of radiation with an immunotherapy drug could help control advanced head and neck cancer. It involved 21 adults whose cancer had returned or spread and was no longer curable with standard surgery or radiation. The goal w…
Matched conditions: RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First human trial tests 'Supercharged' donor cells against tough head & neck cancers
Disease control CompletedThis early-stage study tested the safety of a new combination treatment for advanced head and neck cancer. It involved giving patients immune cells from a donor, along with several drugs, to see if the body could better fight the cancer. The main goal was to find a safe dose and …
Matched conditions: RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC